Nasopharyngeal swabs
Nasopharyngeal swabs is a biological therapy with 4 clinical trials. Historical success rate of 50.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
50.0%
2 of 4 finished
50.0%
2 ended early
0
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism
COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur
A Prospective Epidemiological Study Evaluating Occurrences of Influenza-like Illness
A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom
Clinical Trials (4)
SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism
COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur
A Prospective Epidemiological Study Evaluating Occurrences of Influenza-like Illness
A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4